Skip to main content

GSK Renews Site License for Golden Helix's Software

NEW YORK (GenomeWeb News) - Golden Helix said today that GlaxoSmithKline has renewed a site license for its HelixTree genetic analysis software.
 
HelixTree is a statistical analysis package for analyzing data from whole-genome association studies.
 
Golden Helix said it initially developed the software in 1998 through a collaboration with GSK.
 
Financial terms of the agreement were not released.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.